No Picture
News

Opinion: Changing how buildings use energy can help combat climate change

Shifting buildings away from using dirty fossil fuels and toward using electricity for heating and cooling will be a crucial part of combatting climate change. But decarbonizing buildings would require a whopping increase in demand for renewable energy sources such as wind or solar. Click here to view original post… […]

No Picture
News

Newton-Wellesley Hospital Nurses Vote for New Contract that Invests in Caregivers to Improve Patient Care and Help Overcome COVID-19 Staffing Impacts

The contract agreement followed months of bargaining and a focused effort by NWH nurses to convince the hospital to provide the resources nurses and patients need NEWTON, Mass., Sept. 30, 2022 /PRNewswire/ — The registered nurses of Newton-Wellesley Hospital, represented by the… Click here to view original post… […]

No Picture
News

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from exploratory endpoints and additional analyses of prespecified patient subgroups for the primary and secondary endpoints in the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated… Click here to view original post… […]

No Picture
News

Blue Cross Blue Shield of Massachusetts Expedites Access to Care for Members Affected by Hurricane Ian

BOSTON, Sept. 30, 2022 /PRNewswire/ — In response to the states of emergency declared in Florida, Georgia, South Carolina, North Carolina, and Virginia in anticipation of Hurricane Ian, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may… Click here to view original post… […]

No Picture
News

Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA’s 82nd Scientific Sessions, Are Published This Week in the New England Journal of Medicine

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Pending 510k clearance. CONCORD, Mass., Sept. 30, 2022 /PRNewswire/ — Beta Bionics, Inc. — The results of the multi-center randomized… Click here to view original post… […]

No Picture
News

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing

WATERTOWN, Mass.–(BUSINESS WIRE)–EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to synthesize RNA oligonucleotides, today formally launched with $12 million in seed financing. The round was led by Northpond Ventures with participation from Breakout Ventures, Coatue, and angel investors. The financing will support continued development and scaling… Click here to view original post… […]

No Picture
News

IMV Provides an Update on The VITALIZE Trial

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $IMV #DeliveryPlatform–IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today provided an update on the open-label VITALIZE study evaluating its lead product maveropepimut-S… Click here to view original post… […]

No Picture
News

‘Don’t eat me’ upstart taps Takeda vet on path to the clinic; Greg Mayes leaves Antios for Canadian psychedelics player

Nenad Grmusa Nenad Grmusa was “really happy” at Takeda, where he’d been for more than a decade in various R&D strategy and finance positions. However, the more he learned about DEM BioPharma, the more intrigued he became by cancer’s unexplored “don’t eat me” signals. Jonathan… Click here to view original post… […]